<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01481376</url>
  </required_header>
  <id_info>
    <org_study_id>COVPTAP0161</org_study_id>
    <nct_id>NCT01481376</nct_id>
  </id_info>
  <brief_title>TAPP Inguinal Hernia Repair With Self-fixating Parietex™ ProGrip™ Mesh</brief_title>
  <official_title>Laparoscopic Transabdominal Preperitoneal (TAPP) Inguinal Hernia Repair With Self-fixating Parietex™ ProGrip™ Mesh: A Retrospective Study With 12 Month Follow-up</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic - MITG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic - MITG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this retrospective study is to evaluate the postoperative clinical outcomes
      at discharge, 1 month and 12 months, associated with the use of Parietex™ ProGrip™ in
      Laparoscopic Transabdominal preperitoneal inguinal hernia repair. Results from this study
      will be used to support the short- and long-term clinical outcomes of Parietex™ ProGrip™ when
      used in inguinal hernia repair by laparoscopic approach.

        -  Single center study

        -  Population: All subjects have undergone Laparoscopic Transabdominal preperitoneal
           surgical treatment for inguinal hernia repair with Parietex™ ProGrip™ without additional
           fixation between September 2008 and March 2010 (inclusive) with at least 12 months of
           follow-up.

      The primary outcome:

      • Proportion of subjects who experience hernia recurrence (defect treated initially with
      Parietex™ ProGrip™) within 12 months post-surgery.

      Recurrence is defined as a clinically manifest bulge or a protrusion exacerbated by a
      Valsalva maneuver in the operated groin.

      The recurrence symptoms are assessed by phone based on the Symptoms Questionnaire and the
      recurrence diagnosis is confirmed during a physical examination by a physician and defined as
      a clinically manifest bulge or a protrusion exacerbated by a Valsalva maneuver in the
      operated groin. If subject has a surgical repair of the hernia within the 12 month
      postoperative period, it will be documented as evidence of hernia recurrence.

      The secondary outcome:

        -  Incidence of Groin Pain (pain score 0-10) and analgesic use at discharge, 1 month and 12
           month postoperatively

        -  Incidence of postoperative complications including, wound infection (any infection of
           the incision), mesh infection (an infection of the mesh), bleeding, mesh migration, mesh
           erosion, fistula, small bowel obstruction, seroma, hematuria, hematoma, inflammation,
           chronic pains/ inguinodynia, infection, visceral adherence, allergic reactions to the
           components of the product at discharge, 1month and 12 month post-operatively

        -  Patient satisfaction

        -  Operative time

        -  Hospital length of stay
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2011</start_date>
  <completion_date type="Actual">April 2013</completion_date>
  <primary_completion_date type="Actual">October 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of Subjects Who Experience Hernia Recurrence (Defect Treated Initially With Parietex™ ProGrip™) Within 12 Months Post-surgery.</measure>
    <time_frame>At least 12 months post-surgery</time_frame>
    <description>Recurrence is defined as a clinically manifest bulge or a protrusion exacerbated by a Valsalva maneuver in the operated groin. The recurrence symptoms are assessed by phone based on the Symptoms Questionnaire and the recurrence diagnosis is confirmed during a physical examination by a physician.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of Groin Pain (Pain Score 0-10)</measure>
    <time_frame>12 month post-operatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analgesic Use</measure>
    <time_frame>The day of the discharge (an expected average of 1 day), 1month and at least 12 month post-operatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Complications Including, Infection, Seroma, Hematoma, Visceral Adherence, Allergy Etc</measure>
    <time_frame>up to 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction</measure>
    <time_frame>at least 12 month post-operatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative Time</measure>
    <time_frame>From skin incision to closure (The expected median operating time is 36 minutes for unilateral and 50 minutes for bilateral repair)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Length of Stay</measure>
    <time_frame>Duration of the hospital stay (expected average of 1 day)</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">200</enrollment>
  <condition>Postoperative Complications</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All subjects have undergone Laparoscopic Transabdominal preperitoneal surgical treatment
        for inguinal hernia repair with Parietex™ ProGrip™ without additional fixation between
        September 2008 and March 2010 (inclusive) with at least 12 months of follow-up. Subjects
        must meet the protocol outlined eligibility criteria to be included in the study.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The following diagnosis will be included:

               -  Inguinal hernia: unilateral or bilateral

        All subjects must meet the following inclusion criteria:

          -  ≥18 years of age

          -  Had undergone elective (non-emergent) primary surgical repair of the above diagnosis
             with Parietex ProGrip™ by Laparoscopic Transabdominal preperitoneal inguinal hernia
             repair between September 2008 to March 2010

          -  Post-operative follow-up ≥ 12 months or recurrence which occurs within the 12 months
             post-surgery (If subject has a known incidence of recurrence before the 12 months
             follow up, the subject will be included in the study.)

        Exclusion Criteria:

          -  Subjects who meet any of the following exclusion criteria are not eligible for study
             participation:

               -  Patients with previous laparoscopic Inguinal hernia repair

               -  Emergency procedures

               -  Patients with incarcerated hernias
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dieter BIRK, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Evangelisches Krankenhaus Zweibrücken - Obere Himmelsbergstr. 38 - 66482 Zweibrücken - GERMANY</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Evangelisches Krankenhaus Zweibrücken - Obere Himmelsbergstr. 38</name>
      <address>
        <city>Zweibrücken</city>
        <zip>66482</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 24, 2011</study_first_submitted>
  <study_first_submitted_qc>November 23, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 29, 2011</study_first_posted>
  <results_first_submitted>December 6, 2013</results_first_submitted>
  <results_first_submitted_qc>January 29, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 17, 2014</results_first_posted>
  <last_update_submitted>December 8, 2015</last_update_submitted>
  <last_update_submitted_qc>December 8, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Parietex™ ProGrip™</keyword>
  <keyword>Laparoscopic Transabdominal preperitoneal</keyword>
  <keyword>TAPP</keyword>
  <keyword>Inguinal hernia repair</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Inguinal</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Parietex Progrip</title>
          <description>Surgical cure of inguinal hernia using the Parietex™ ProGrip™ mesh by Laparoscopic Transabdominal Preperitoneal (TAPP) approach</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="200"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="169"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="31"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Parietex Progrip</title>
          <description>Surgical cure of inguinal hernia using the Parietex™ ProGrip™ mesh by Laparoscopic Transabdominal Preperitoneal (TAPP) approach</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="169"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54.7" lower_limit="21" upper_limit="86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="156"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Proportion of Subjects Who Experience Hernia Recurrence (Defect Treated Initially With Parietex™ ProGrip™) Within 12 Months Post-surgery.</title>
        <description>Recurrence is defined as a clinically manifest bulge or a protrusion exacerbated by a Valsalva maneuver in the operated groin. The recurrence symptoms are assessed by phone based on the Symptoms Questionnaire and the recurrence diagnosis is confirmed during a physical examination by a physician.</description>
        <time_frame>At least 12 months post-surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Parietex Progrip</title>
            <description>Surgical cure of inguinal hernia using the Parietex™ ProGrip™ mesh by Laparoscopic Transabdominal Preperitoneal (TAPP) approach</description>
          </group>
        </group_list>
        <measure>
          <title>Proportion of Subjects Who Experience Hernia Recurrence (Defect Treated Initially With Parietex™ ProGrip™) Within 12 Months Post-surgery.</title>
          <description>Recurrence is defined as a clinically manifest bulge or a protrusion exacerbated by a Valsalva maneuver in the operated groin. The recurrence symptoms are assessed by phone based on the Symptoms Questionnaire and the recurrence diagnosis is confirmed during a physical examination by a physician.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="169"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Incidence of Groin Pain (Pain Score 0-10)</title>
        <time_frame>12 month post-operatively</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Parietex Progrip</title>
            <description>Surgical cure of inguinal hernia using the Parietex™ ProGrip™ mesh by Laparoscopic Transabdominal Preperitoneal (TAPP) approach</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of Groin Pain (Pain Score 0-10)</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="168"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>No/Low Pain (score 0-3)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="160"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mild pain (Score 4-6)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Severe (score 7-10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Analgesic Use</title>
        <time_frame>The day of the discharge (an expected average of 1 day), 1month and at least 12 month post-operatively</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Postoperative Complications Including, Infection, Seroma, Hematoma, Visceral Adherence, Allergy Etc</title>
        <time_frame>up to 12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Parietex Progrip</title>
            <description>Surgical cure of inguinal hernia using the Parietex™ ProGrip™ mesh by Laparoscopic Transabdominal Preperitoneal (TAPP) approach</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Complications Including, Infection, Seroma, Hematoma, Visceral Adherence, Allergy Etc</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="169"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Hematoma/Seroma</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Emphysema in the inguinal regions (both sides)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Secondary hemorrhage through the trocar’s site</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hematuria</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling above the genital organs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Satisfaction</title>
        <time_frame>at least 12 month post-operatively</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Parietex Progrip</title>
            <description>Surgical cure of inguinal hernia using the Parietex™ ProGrip™ mesh by Laparoscopic Transabdominal Preperitoneal (TAPP) approach</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Satisfaction</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="169"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Very satisfied/Satisfied</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="162"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Neutral</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unsatisfied/Very unsatisfied</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Operative Time</title>
        <time_frame>From skin incision to closure (The expected median operating time is 36 minutes for unilateral and 50 minutes for bilateral repair)</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hospital Length of Stay</title>
        <time_frame>Duration of the hospital stay (expected average of 1 day)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Parietex Progrip</title>
            <description>Surgical cure of inguinal hernia using the Parietex™ ProGrip™ mesh by Laparoscopic Transabdominal Preperitoneal (TAPP) approach</description>
          </group>
        </group_list>
        <measure>
          <title>Hospital Length of Stay</title>
          <units>Days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="169"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Parietex Progrip</title>
          <description>Surgical cure of inguinal hernia using the Parietex™ ProGrip™ mesh by Laparoscopic Transabdominal Preperitoneal (TAPP) approach</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="169"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="169"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Docteur Dieter BIRK</name_or_title>
      <organization>Surgical Department of the Protestant Hospital</organization>
      <phone>06332 422120</phone>
    </point_of_contact>
  </clinical_results>
</clinical_study>

